Drug news and alerts

January 16, 2020

The FDA continues to monitor and may add more manufacturers to the recall for ranitidine, a drug used to treat ulcers and other conditions where reduction of gastric secretion and acid output is desirable.

Ongoing drug recall notice for ranitidine, PDF opens new window

September 26, 2019

The manufacturer of NATPARA, a drug used to treat hypocalcemia in patients with hypoparathyroidism, is issuing a recall of all doses on the market because of a potential issue.

Drug recall notice for Natpara, PDF opens new window

January 21, 2019

The Food and Drug Administration (FDA) has issued a voluntary recall of select irbesartan-containing drugs due to an impurity used in the manufacturing of these medicines.

Drug recall notice for irbesartan and irbesartan-containing drug products, PDF opens new window

January 4, 2019

The Food and Drug Administration (FDA) has issued a voluntarily recall of select losartan containing drugs due to an impurity used in the manufacturing of these medicines.

Drug recall notice for losartan and losartan-containing drug products, PDF opens new window

November 20, 2018

The Food and Drug Administration (FDA) has issued a voluntary recall of select generic valsartan and valsartan containing drugs due to an impurity used in the manufacturing of these medicines.

Drug recall notice for valsartan and valsartan containing drug products, PDF opens new window

August 6, 2018

Novartis and Sandoz Inc. have voluntarily recalled certain blister card packages distributed in the U.S.

Drug recall notice for Ondansetron Orally Disintegrating Tablets (ODT) and Risperidone Orally Disintegrating Tablets, PDF opens new window

June 1, 2017

The maker of Ventolin HFA Inhaler® has voluntarily recalled select lots from the U.S. marketplace. This recall was initiated due to a defect in certain lots of the inhaler that causes the product to deliver fewer doses than indicated.

Drug recall notice for Ventolin HFA Inhaler, PDF opens new window

June 1, 2017

The maker of EpiPen® and EpiPen Jr® Auto-Injectors has voluntarily recalled selected lots distributed in the U.S. and other markets. This recall was initiated due to reports of possible device malfunctions that could result in the devices failing to activate or requiring increased force to activate in an emergency or life-threatening situation.

Drug recall notice for the EpiPen and EpiPen Jr Auto-Injector, PDF opens new window